Inactive Instrument

Highlights Summit Therapeutics plc London S.E.

Equities

GB00BN40HZ01

Highlights

Unlock all the news: Be the first to know and act before the market!

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	31/05	MT
Wall Street Set to Open Modestly Higher Friday as Key Inflation Data Meets Expectations	31/05	MT
Sector Update: Health Care	31/05	MT
Health Care Stocks Steady -- Health Care Roundup	31/05	DJ
Summit Therapeutics Inc. Announces Phase III Clinical Trial, HARMONI-2 or AK112-303 Met its Primary Endpoint of Progression-Free Survival	31/05	CI
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected	31/05	MT
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar	31/05	MT
Summit Therapeutics Shares Triple After Drug Candidate Data	31/05	DJ
Summit Therapeutics cancer therapy succeeds in late-stage China study	31/05	RE
Sector Update: Health Care Stocks Decline Late Friday Afternoon	25/05	MT
Summit Therapeutics Shares Fall After Late-Stage Topline Data for Lung Cancer Treatment Announced	24/05	MT
Top Premarket Decliners	24/05	MT
Summit Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05	CI
Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans	01/04	MT
Summit Therapeutics Reports 23% Complete Response in Metastatic NSCL Cancer Drug Ivonescimab's Clinical Trials	22/03	MT
Summit Therapeutics Inc. Announces Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024	22/03	CI
Akeso Logs First-Ever Profit in 2023; Beats EPS Forecast	19/03	MT
Summit Therapeutics Inc. Announces That Data for Its Novel, Potential First-In-Class Investigational Bispecific Antibody, Ivonescimab, Will Be Presented At the 2024 European Lung Cancer Congress (Elcc 2024) in Prague, Czech Republic	14/03	CI
Akeso Books First-Ever Profit in 2023; Shares Fall 5%	05/03	MT
Summit Therapeutics Q4 Loss Widens	20/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Summit Therapeutics plc London S.E.

Equities

GB00BN40HZ01

Highlights

Filters